| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of ST3GAL5 mRNA | decreases expression | 19933214
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of ST3GAL5 mRNA | affects expression | 17562736
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ST3GAL5 protein | affects expression | 20106945
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ST3GAL5 mRNA | affects expression | 16483693
|
| D002087 |
Butyrates |
Butyrates results in increased expression of ST3GAL5 mRNA | increases expression | 15541394
|
| D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of ST3GAL5 mRNA | affects expression | 17484886
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ST3GAL5 mRNA | decreases expression | 20106945
|
| D004281 |
Docosahexaenoic Acids |
Docosahexaenoic Acids results in increased expression of ST3GAL5 mRNA | increases expression | 19805517
|
| D004281 |
Docosahexaenoic Acids |
PPARD protein promotes the reaction [Docosahexaenoic Acids results in increased expression of ST3GAL5 mRNA] | increases expression|increases reaction | 19805517
|
| D004317 |
Doxorubicin |
ST3GAL5 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 16571667
|
| D005047 |
Etoposide |
ST3GAL5 protein results in decreased susceptibility to Etoposide | decreases response to substance | 16571667
|
| D005230 |
Fatty Acids, Nonesterified |
Fatty Acids, Nonesterified promotes the reaction [PPARD protein binds to ST3GAL5 enhancer] | affects binding|increases reaction | 19805517
|
| D005679 |
G(M3) Ganglioside |
ST3GAL5 protein results in increased chemical synthesis of G(M3) Ganglioside | increases chemical synthesis | 16571667
|
| C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of ST3GAL5 mRNA | increases expression | 17681415
|
| D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ST3GAL5 mRNA] | affects reaction|decreases expression | 19482888
|
| D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of ST3GAL5 mRNA | decreases expression | 19482888
|
| D010634 |
Phenobarbital |
Phenobarbital results in increased expression of ST3GAL5 mRNA | increases expression | 19270015
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ST3GAL5 mRNA | affects binding|increases activity|increases expression | 19710929
|
| C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ST3GAL5 mRNA | increases expression | 18445702 18301758
|
| D013311 |
Streptozocin |
Streptozocin results in increased expression of ST3GAL5 mRNA | increases expression | 16684804
|
| D013311 |
Streptozocin |
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of ST3GAL5 mRNA] | decreases reaction|increases expression | 16684804
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ST3GAL5 mRNA | decreases expression | 19933214
|
| D014635 |
Valproic Acid |
Valproic Acid results in increased expression of ST3GAL5 mRNA | increases expression | 19101580
|
| C034028 |
vanadyl sulfate |
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of ST3GAL5 mRNA] | decreases reaction|increases expression | 16684804
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
13.85 | 6195326 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
13.85 | 15322242 14514962 11752688 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
13.85 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.86 | 19490988 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.50 | 18287403 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.05 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.55 | 17418594 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
16.94 | 17620307 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
16.94 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.94 | 16835633 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.48 | 21441931 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.18 | 17688650 |
| OMIM:609056 |
AMISH INFANTILE EPILEPSY SYNDROME |
marker/mechanism |
|
| |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.89 | 11748828 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.79 | 10982225 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.52 | 17497229 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.25 | 18445737 |
| MESH:D001321 |
Autistic Disorder |
|
Docosahexaenoic Acids |
2.25 | 18582451 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.25 | 17507914 19232924 18316065 19460635 17157402 15238991 18775368 20603192 18396377 18940202 18558336 18177632 17688650 18985861 16609825 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.04 | 17594078 20046352 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.56 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.56 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.88 | 15746008 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.88 | 8888407 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.97 | 14601052 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
11.97 | 14601052 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.75 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.99 | 16096432 16322301 15136595 15994142 15939500 15567936 18234424 15993339 15668708 16826403 16115903 17426702 18628466 18695136 11325840 18382427 19526202 16935488 17369602 15692762 17983394 16264153 15634643 16595493 |
| MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
1.99 | 16322251 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.99 | 20435547 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.72 | 16011737 16097048 18705752 16192424 3786805 15673190 16050911 16227642 10355542 15721981 15700767 16124888 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
12.51 | 16051944 |
| MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
12.51 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.74 | 16835633 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.76 | 3084413 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
8.76 | 12907637 12619106 21507988 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
8.76 | 18788625 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
8.76 | 16234567 16023760 18059187 17876044 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
8.76 | 6705139 1701930 20007298 17173139 20935162 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.13 | 1485588 16201981 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.62 | 6189445 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.33 | 16120746 18850075 18670907 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.48 | 18627295 17519947 16278810 17007740 16651473 17308081 16612575 15505089 15811867 16364871 17974986 17329180 16242529 17131338 17382496 15476868 15792986 16109756 16731534 16455267 17928571 17924179 16269455 16952015 17351982 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.92 | 16243910 17334414 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.54 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.48 | 12371664 |
| MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.19 | 4080065 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.68 | 20734317 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.10 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.59 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.59 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 8697196 15340226 16354765 15668235 12621046 |
| MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
3.07 | 15936596 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.45 | 20055451 10048152 15322242 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.45 | 8888407 17688650 16575769 |
| MESH:D003550 |
Cystic Fibrosis |
|
Docosahexaenoic Acids |
4.61 | 19747007 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.39 | 18249437 |
| MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
4.67 | 16285004 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
8.87 | 12083368 2177838 19586609 12644472 1374869 6379147 18715473 19960420 15831366 16684804 15862027 19298542 12446591 7637645 18603373 17442507 8740154 16286809 15298345 17874149 11260395 11055810 12093613 19496084 |
| MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
8.87 | 16684804 |
| MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
3.61 | 18603373 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
4.60 | 19586609 19647726 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.60 | 17107852 |
| MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.66 | 16025228 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
4.61 | 19960420 19682444 |
| MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
5.36 | 17662242 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.81 | 14986274 17906064 19085960 15619225 17562736 12705907 11421492 16781746 16227642 12392966 11461765 14725611 16177239 12540782 19164858 14550746 18071297 19739265 16081117 2444490 15968718 19923254 12594235 10915739 17522070 19420014 16109766 11739529 19370779 10663392 11834606 11743745 19416960 18713872 16393943 11529661 12958197 10774834 16485898 12153990 11287661 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
11.81 | 21278145 11566570 7179309 15998439 2869522 3786805 7440962 16177239 10915739 3732212 7120509 15968718 6884620 15027814 4309450 6623471 16227642 10092053 9327722 17522070 19336974 19085960 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
11.81 | 17416283 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.81 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
11.81 | 19641884 1733752 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.04 | 19426721 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
7.94 | 18602426 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.94 | 11462148 |
| MESH:D004421 |
Dystonia |
|
Phenobarbital |
10.22 | 1851702 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
10.22 | 1851702 |
| MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
11.11 | 17259670 12083418 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
11.11 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.11 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.85 | 15322242 16714409 18230668 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.41 | 17359293 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.96 | 9294722 10568697 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.10 | 18037988 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
10.58 | 3659116 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
10.58 | 17275665 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
9.79 | 3922381 11558140 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
9.79 | 16628512 3922381 |
| MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.55 | 20417680 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
6.55 | 18234410 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
8.67 | 6401628 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
8.67 | 6254150 7562514 6426943 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
11.09 | 7750514 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
11.09 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
10.28 | 3659116 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
10.28 | 3659116 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
18.25 | 16045604 17595544 12795759 19224547 12631006 16239168 15959796 61145 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.25 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.25 | 20131406 19236843 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
18.25 | 14986274 19224547 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.39 | 11858732 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.83 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.07 | 8888407 18558336 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.53 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
14.35 | 18705752 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.35 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.35 | 20067830 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.62 | 16983495 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.16 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.31 | 17150277 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.54 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.48 | 15692506 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.30 | 11294989 10048152 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
7.96 | 16330681 16495754 14766674 16244371 16879835 16144979 17888722 17875725 12587719 16707910 18674790 16244372 18006777 |
| MESH:D006331 |
Heart Diseases |
|
Streptozocin |
7.96 | 12093613 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.91 | 17481944 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.91 | 20558911 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.84 | 15692506 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.36 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.27 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.53 | 19110552 19900420 |
| MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
20.18 | 3609246 |
| MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
20.18 | 16109766 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
20.18 | 19176532 16221962 18467677 19772884 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
20.18 | 15340226 16120746 12621046 |
| MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.50 | 10809021 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.55 | 18501091 17606976 15147373 |
| MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
7.55 | 17606976 16200630 15147373 18180244 16135485 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.81 | 17688650 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.99 | 8697196 15340226 16959395 18606429 16354765 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.68 | 16870215 |
| MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.68 | 12083418 |
| MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.47 | 16899240 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.12 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.86 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.86 | 18670907 18850075 |
| MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.02 | 15338365 |
| MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
5.03 | 12083418 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.03 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.59 | 16306350 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.39 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.18 | 12587719 15629191 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.18 | 8314463 10903974 18776723 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
14.18 | 15699352 16775033 15369732 |
| MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
14.18 | 12093613 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.09 | 16707910 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.68 | 12371664 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.10 | 16085563 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Docosahexaenoic Acids |
4.94 | 17077332 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.14 | 16294345 17596541 |
| MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.17 | 8812269 |
| MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.51 | 11903743 16239168 16943688 17334410 11408273 17157831 21278145 16221502 17174718 |
| MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.51 | 21047994 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
4.87 | 14620537 16027843 12958196 15876570 15925388 16015684 18156304 18395095 17708605 18420326 15362042 17976157 17698563 17565644 17805973 18705752 15996030 14748882 18412020 14716496 15338365 18277467 10355542 18166357 12389079 11481614 18395914 17823541 12741479 17640975 18376398 15650968 18279442 17944888 13678700 12609069 15818738 16116963 17766677 15057751 17761835 15052691 18429990 18418968 15370692 16033810 14512876 18263696 12586293 16011737 16192424 18317297 16248980 15893842 18187930 15959796 15931870 14724832 18472094 14716833 18251166 18481824 15673190 16097048 18205269 12445421 16136751 17525996 17714472 12667390 18210741 20821823 18339082 12666154 17721639 18472332 15730626 17900296 12546737 17869086 12632512 17481882 17631135 15123356 18054572 12649538 18006644 17922224 12898905 12632514 17557913 16638106 12445418 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.87 | 16439617 16595196 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.87 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.87 | 12878042 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
9.30 | 12969438 19014921 16611625 11587558 12587719 19784758 16610002 19460945 |
| MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
9.30 | 17285989 16964402 15720792 16246199 15830285 |
| MESH:D008107 |
Liver Diseases |
|
Docosahexaenoic Acids |
9.30 | 17056761 |
| MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
9.30 | 19363144 |
| MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.10 | 15123358 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.21 | 17185352 16871587 |
| MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
9.21 | 16899240 14706259 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
17.67 | 15890375 9163691 2125692 18177683 |
| MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
17.67 | 19294768 |
| MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
17.67 | 18709148 14757943 |
| MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
17.67 | 19073162 19812893 8742319 19482888 15975961 21047994 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
17.67 | 20007298 15890375 16377806 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.67 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
18.21 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
18.21 | 12014681 15583823 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
18.21 | 17085340 16842330 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
18.21 | 18308698 6150874 17172636 2563599 1399818 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
18.21 | 12151625 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.21 | 17228818 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.40 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.40 | 6189445 17418594 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.40 | 11884234 19555203 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.75 | 16098063 |
| MESH:D008223 |
Lymphoma |
|
Etoposide |
7.75 | 12556972 12854902 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.73 | 17654614 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.50 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
2.99 | 15458769 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.28 | 16827129 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.50 | 19513568 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.03 | 17638057 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.73 | 16801185 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.14 | 18765137 18803445 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.44 | 15792986 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.73 | 17415656 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.44 | 16239165 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.96 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.12 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.62 | 19429709 15857846 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.62 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.96 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.89 | 16411023 |
| MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.41 | 17484760 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.93 | 18259882 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.92 | 17405874 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.70 | 16899518 16636307 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.39 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.10 | 19348381 18481113 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.10 | 16889571 15640375 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.15 | 14600291 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.08 | 16359493 8888407 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.23 | 15555623 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.81 | 18514411 |
| MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.89 | 9802331 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.80 | 20558911 |
| MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.30 | 17016548 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.06 | 15930896 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.34 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
5.49 | 19003803 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.49 | 16965848 |
| MESH:D010195 |
Pancreatitis |
|
Fatty Acids, Nonesterified |
5.43 | 18983441 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.19 | 12520081 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.10 | 17983394 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.10 | 17638057 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.49 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.78 | 12371664 |
| MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.78 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
15.96 | 17132714 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.96 | 11399792 11118676 11222880 11896295 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
15.96 | 20603192 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.69 | 18437689 15897917 16888761 16868541 16729912 15749863 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
3.69 | 17172428 |
| MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
12.00 | 12752131 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
12.00 | 12752131 11422049 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.21 | 16882103 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.16 | 17922066 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.35 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 18990726 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.11 | 19155313 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.93 | 17203757 16767912 17710206 15625365 15675481 18313854 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
10.34 | 16326096 14601052 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
10.34 | 14601052 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.73 | 17846226 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 15737665 19110320 |
| MESH:D012640 |
Seizures |
|
Phenobarbital |
5.85 | 3137016 4039156 11442880 16876388 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
5.85 | 1511512 14763951 17978042 16876388 3137016 15475178 11738929 11044598 |
| MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.76 | 6407741 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.58 | 15692506 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.58 | 16192470 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.50 | 17203757 15625365 16767912 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.73 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.49 | 12833885 |
| MESH:D013274 |
Stomach Neoplasms |
|
Docosahexaenoic Acids |
3.06 | 19015929 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.85 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
11.87 | 17967635 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.87 | 17909728 16010429 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
11.87 | 1399818 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.18 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.46 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.74 | 17653716 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.58 | 8888407 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.91 | 10982225 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.93 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.54 | 12125929 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.16 | 17678736 16364871 17638931 17334414 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.19 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.39 | 17120751 |